Hormone therapyFDA-approvedAdjuvant
Zoladex
Generic name: goserelin
How it works
Blocks the production of hormones that can fuel the growth of ovarian cancer cells.
Cancer types
Efficacy
Studies show that Zoladex can improve overall survival and response rates in ovarian cancer patients, particularly when used in combination with chemotherapy.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Ovarian Function Suppression in Breast Cancer Patients | Breast Cancer | phase-2 | — | Source → |
| Evaluating Ovarian Suppression in Premenopausal Women with Advanced Breast Cancer | Breast Cancer | phase-1 | — | Source → |
| New Patch for Prostate Cancer Treatment | Prostate Cancer | lab-study | — | Source → |
| Comparing Gonadotropin-Releasing Hormone Agonists for Prostate Cancer Treatment | Prostate Cancer | review | The 10-year overall survival rate was 42.6% to 86% when only goserelin was used in the neoadjuvant setting. | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.